These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26890675)

  • 1. Whole-Genome Sequencing of Methicillin-Resistant Staphylococcus aureus Resistant to Fifth-Generation Cephalosporins Reveals Potential Non-mecA Mechanisms of Resistance.
    Greninger AL; Chatterjee SS; Chan LC; Hamilton SM; Chambers HF; Chiu CY
    PLoS One; 2016; 11(2):e0149541. PubMed ID: 26890675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum β-lactam resistance in
    Lai L-Y; Satishkumar N; Cardozo S; Hemmadi V; Marques LB; Huang L; Filipe SR; Pinho MG; Chambers HF; Chatterjee SS
    mBio; 2024 May; 15(5):e0288923. PubMed ID: 38530033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Level Resistance of Staphylococcus aureus to β-Lactam Antibiotics Mediated by Penicillin-Binding Protein 4 (PBP4).
    Hamilton SM; Alexander JAN; Choo EJ; Basuino L; da Costa TM; Severin A; Chung M; Aedo S; Strynadka NCJ; Tomasz A; Chatterjee SS; Chambers HF
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and kinetic analyses of penicillin-binding protein 4 (PBP4)-mediated antibiotic resistance in
    Alexander JAN; Chatterjee SS; Hamilton SM; Eltis LD; Chambers HF; Strynadka NCJ
    J Biol Chem; 2018 Dec; 293(51):19854-19865. PubMed ID: 30366985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missense mutations of PBP2a are associated with reduced susceptibility to ceftaroline and ceftobiprole in African MRSA.
    Schaumburg F; Peters G; Alabi A; Becker K; Idelevich EA
    J Antimicrob Chemother; 2016 Jan; 71(1):41-4. PubMed ID: 26443816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftobiprole- and ceftaroline-resistant methicillin-resistant Staphylococcus aureus.
    Chan LC; Basuino L; Diep B; Hamilton S; Chatterjee SS; Chambers HF
    Antimicrob Agents Chemother; 2015 May; 59(5):2960-3. PubMed ID: 25753637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro selection and characterization of ceftobiprole-resistant methicillin-resistant Staphylococcus aureus.
    Banerjee R; Gretes M; Basuino L; Strynadka N; Chambers HF
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2089-96. PubMed ID: 18378703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PBP 4 Mediates High-Level Resistance to New-Generation Cephalosporins in Staphylococcus aureus.
    Chan LC; Gilbert A; Basuino L; da Costa TM; Hamilton SM; Dos Santos KR; Chambers HF; Chatterjee SS
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3934-41. PubMed ID: 27067335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftaroline Resistance by Clone-Specific Polymorphism in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus.
    Lee H; Yoon EJ; Kim D; Kim JW; Lee KJ; Kim HS; Kim YR; Shin JH; Shin JH; Shin KS; Kim YA; Uh Y; Jeong SH
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.
    Mendes RE; Tsakris A; Sader HS; Jones RN; Biek D; McGhee P; Appelbaum PC; Kosowska-Shick K
    J Antimicrob Chemother; 2012 Jun; 67(6):1321-4. PubMed ID: 22398650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective.
    Alm RA; McLaughlin RE; Kos VN; Sader HS; Iaconis JP; Lahiri SD
    J Antimicrob Chemother; 2014 Aug; 69(8):2065-75. PubMed ID: 24777906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic analysis of Italian MRSA strains exhibiting low-level ceftaroline and ceftobiprole resistance.
    Bongiorno D; Mongelli G; Stefani S; Campanile F
    Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114852. PubMed ID: 31288948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of methicillin-resistant Staphylococcus aureus: Evidence of positive selection in a penicillin-binding protein (PBP) 2a coding gene mecA.
    Zhan XY; Zhu QY
    Infect Genet Evol; 2018 Apr; 59():16-22. PubMed ID: 29413881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftaroline is active against heteroresistant methicillin-resistant Staphylococcus aureus clinical strains despite associated mutational mechanisms and intermediate levels of resistance.
    Fernandez R; Paz LI; Rosato RR; Rosato AE
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5736-46. PubMed ID: 25022592
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Gostev V; Sopova J; Kalinogorskaya O; Tsvetkova I; Lobzin Y; Klotchenko S; Sidorenko S
    Microb Drug Resist; 2019 Dec; 25(10):1401-1409. PubMed ID: 31329022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Rate of Ceftobiprole Resistance among Clinical Methicillin-Resistant
    Morroni G; Brenciani A; Brescini L; Fioriti S; Simoni S; Pocognoli A; Mingoia M; Giovanetti E; Barchiesi F; Giacometti A; Cirioni O
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility testing of ceftobiprole against 880 European respiratory tract infection isolates of methicillin-resistant Staphylococcus aureus followed by whole genome sequencing of ceftobiprole-resistant isolates.
    Hawser S; Kothari N; Karlowsky JA; Wiktorowicz T; Hamed K
    Diagn Microbiol Infect Dis; 2020 Apr; 96(4):114978. PubMed ID: 31952866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals.
    Andrey DO; François P; Manzano C; Bonetti EJ; Harbarth S; Schrenzel J; Kelley WL; Renzoni A
    Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):343-350. PubMed ID: 27744604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of non-PBP2a resistance mechanisms in Staphylococcus aureus after serial passage with ceftaroline: involvement of other PBPs.
    Lahiri SD; Alm RA
    J Antimicrob Chemother; 2016 Nov; 71(11):3050-3057. PubMed ID: 27494915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the evolutionary steps leading to mecA-mediated β-lactam resistance in staphylococci.
    Rolo J; Worning P; Boye Nielsen J; Sobral R; Bowden R; Bouchami O; Damborg P; Guardabassi L; Perreten V; Westh H; Tomasz A; de Lencastre H; Miragaia M
    PLoS Genet; 2017 Apr; 13(4):e1006674. PubMed ID: 28394942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.